The European Brain Council (EBC) has published its 2024 Annual Report, reflecting on and celebrating the organisation’s accomplishments in brain advocacy at national, European, and global levels in the previous calendar year.

The fourth EAN Science School took place in Salzburg, Austria on 21-25 March, bringing together 65 participants from 23 countries.

For the first time, guidelines for the management of urogenital symptoms reported by have been developed specifically for neurologists through a collaboration between the EAN, the International Neuro-Urology Society (INUS) and the European Federation of Autonomic Societies (EFAS).

The EAN was asked by a media outlet to provide comment on the possible role of creatine in the prevention of Alzheimer’s disease, the subject of much recent internet speculation.

Following an earlier decision by the EMA, the EU Commission has granted EU authorisation for Lecanemab to treat mild cognitive impairment in the early stages of Alzheimer’s disease.

Neurotorium - an educational platform providing for clinicians, educators, researchers - welcomes applications for funding of non-profit educational projects aimed at healthcare professionals.

We are immensely proud to announce that the 10th Congress of the European Academy of Neurology, held at the Messukeskus, Helsinki, in 2024, has been named Best Corporate Event Subject to a Fee at the 2024 Evento Awards, a Finnish event industry award that recognises the best events, venues, speakers, creators and companies in Finland.

Each month the eanNews editorial team reviews the scientific press for recently published papers of outstanding interest to neurologists. Here we present our selection for April 2025.

There is still time to catch our early registration fee for EAN 2025 before the end of 16 April. Plus: Late Breaking Abstract Submission is now open!

EAN Communications Committee Chair, Matilde Leonardi, looks back on an extremely busy and productive period of communication activity for the EAN.

Welcome to the April 2025 edition of the President’s Corner, our article series in which the EAN President, Elena Moro, answers your questions!

Join us for an engaging workshop where you will step into the role of a Task Force member tasked with developing an EAN clinical guideline for the use of selective anti-Aβ monoclonal antibodies in treating Alzheimer’s disease.

Our Paper of the Month is a prospective cohort study conducted in the US, including participants from the Nurses’ Health Study (NHS) and the Health Professionals Follow-Up Study (HPFS).

The next EAN Autumn School will take in place in Vienna, Austria, on 29 October – 2 November 2025.

Reports from three EAN Research Fellowship participants on their experiences in Lyon, Berlin, and London.